Description: This session provides an overview of industry approaches to valuing the liabilities of nontraditional health products. Liabilities for losses that have been incurred but not reported and for losses that have been reported but not paid are examined. Includes a discussion on employer specific stop-loss, provider excess loss, critical illness and cancer insurance. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 133

Description: This session discussion is about health rate filing regulations for small group and individual products, small group model update and current issues. From Record of Society of Actuaries Vol. 16, No. 4B.

Description: Discusses claim reserves for group long-term disability [GLTD], group medical insurance, and small-group [under 25 lives] medical and dental insurance. Session 9 of the 1991 Valuation Actuary Symposium.

Description: Panel member briefly review the collecting and analyzing of the data and the status of the disability valuation tables. They describe special characteristics of the proposed tables and compare the results with the CDT table and the most recent data published in the 1979 Reports of Mortality and Morbidity Experience.

Description: The focus of the webcast on Modeling Long–Term Medical Trends for Valuation Purposes was a discussion of the underlying methodology of the model, a walk through of the actual model, and a review of the considerations for its practical usage by actuaries. The running time of this video is 1 hour and 3 minutes. It is a presentation of slides without audio.

Description: This session is about NAIC health rate regulations regarding loss ratios, new business/closed-block issues, experience data for reporting, and trend. Topics include alternatives to durational rating, prefunding, and rate spread, From Record of Society of Actuaries Vol. 19, No. 1A.

Description: Presented at October 2001 Annual Meeting. Panelists provide insight into the factors driving the cost increase of prescription drugs and how these factors are being addressed. Strategies include drug utilization review, manufacturer contracting, benefit design, formularies, pharmaceutical pricing, therapeutic substitution, physical education, and introduction of new pharmaceuticals. Also discussed are pharmacoeconomic benefit considerations when studying integrated medical and pharmacy expenses.

Description: Presented at October 1986 Annual Meeting. This session discussion is about the market, products/plan design, administration, underwriting and types of delivery systems.

Description: Presented at October 1985 Annual Meeting. Discusses 3 papers: 'Report on Reserve Standards for Individual and Group Health Insurance Contracts' by the AAA Committee on Health, 'Reserve Principles for Individual Health Insurance' by the Committee for Accident and Health, and 'Structure for Consideration of Health Coverage Valuation Standards' by an NAIC Health Subcommittee of Standing Technical Advisory Group.

Description: Excel file from Health Pricing Boot Camp Session 1: Basic Trend Forecasting Model Case Study